ArriVent BioPharma, Inc. (AVBP) vs Geron Corporation (GERN)
- ArriVent BioPharma, Inc. AVBP 16.66 −0.77%
- Geron Corporation GERN 1.17 −4.88%
ArriVent BioPharma, Inc. and Geron Corporation are both Biotechnology companies. ArriVent BioPharma, Inc. and Geron Corporation are of similar size ($827.9M and $790.2M). ArriVent BioPharma, Inc. has the higher net margin (0.00% vs −33.1%) and the higher return on invested capital (0.00% vs −89.9%). Across the 13 metrics below, ArriVent BioPharma, Inc. leads on 8 and Geron Corporation on 5.
Valuation
Profitability
| Metric | AVBP | GERN | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 93.51% | 65.16% |
| Operating margin | 0.00% | (25.31%) | 0.00% |
| Net margin | 0.00% | (33.05%) | 0.00% |
| Free cash flow margin | 0.00% | (56.10%) | 0.00% |
| Return on equity | (53.10%) | (28.28%) | (56.36%) |
| Return on assets | (49.30%) | (12.59%) | (48.04%) |
| Return on invested capital | 0.00% | (89.85%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack